| LDO Home | General | Kidney | Liver | Marrow | Experiences | Buddies | Hall of Fame | Calendar | Contact Us |

Author Topic: Evaluating a unique enhanced recovery protocol in laparoscopic donor nephrectomy  (Read 780 times)

0 Members and 1 Guest are viewing this topic.

Offline Clark

  • Administrator
  • Top 10 Poster!
  • *****
  • Posts: 3,012
  • Please give the gift of life!
    • Living Donors Online!
https://onlinelibrary.wiley.com/doi/abs/10.1111/ctr.15051?campaign=wolearlyview

Evaluating a unique enhanced recovery protocol in laparoscopic donor nephrectomy: A single center experience

Clinical Transplantation
Early View
Online Version of Record before inclusion in an issue
Samuel W. Atherton, Michael S. Massey, Tho Nguyen, David W. Wang, Kathirvel Subramaniam, Eman Abdelwahid, Ahmed Bahnaswy, Michael S. Trostler, Manuel Lombardero … See all authors
First published: 19 June 2023 https://doi.org/10.1111/ctr.15051

Abstract
Introduction
Enhanced recovery after surgery (ERAS) protocols have been associated with a reduction in opioid consumption and a hastening in recovery in abdominal surgery. However, their impact on laparoscopic donor nephrectomy (LDN) has not been fully elucidated. The aim of this study is to evaluate opioid consumption and other relevant outcome measures before and after implementation of a unique LDN ERAS protocol.
Methods
244 LDN patients were included in this retrospective cohort study. Forty-six underwent LDN prior to implementation of ERAS, whereas 198 patients received ERAS perioperative care. The primary outcome was daily oral morphine equivalent (OME) consumption averaged over the entire postoperative stay. Due to removal of preoperative oral morphine from the protocol partway through the study period, the ERAS group was further subdivided into morphine recipients and non-recipients for subgroup analysis. Secondary outcomes included the incidence of postoperative nausea and vomiting (PONV), length of stay, pain scores, and other relevant measures.
Results
ERAS donors consumed significantly fewer average daily OMEs than Pre-ERAS donors (21.5 vs. 37.6, respectively; p < .0001). There were no statistically significant differences in OME consumption between morphine recipients and non-recipients. The ERAS group experienced less PONV (44.4% requiring one or more rescue antiemetic postoperatively, vs. 60.9% of Pre-ERAS donors; p = .008).
Conclusions
A protocol pairing lidocaine and ketamine with a comprehensive approach to preoperative PO intake, premedication, intraoperative fluid management and postoperative pain control is associated with reduced opioid consumption in LDN.
Unrelated directed kidney donor in 2003, recipient and I both well.
618 time blood and platelet donor since 1976 and still giving!
Elected to the OPTN/UNOS Boards of Directors & Executive, Kidney Transplantation, and Ad Hoc Public Solicitation of Organ Donors Committees, 2005-2011
Proud grandpa!

 

 Subscribe in a reader



Copyright © International Association of Living Organ Donors, Inc. All Rights Reserved
traditional